Please Read Our Disclaimer
Location: Hong Kong
Sector: Logistics Software, Blockchain.
With OpenPort’s platform, users know exactly what was delivered, when, and by whom. They are rewarded for sharing information, and by creating an audit trail for their goods and services can enhance their cash flow and liquidity with the OpenPaid supply chain financing portal.
OpenPort’s solutions deliver transparency to the suppliers, transporters and retailers in the world’s largest supply chains. We solve the cash flow problem created by slow and disputed paper records by providing comprehensive, secure digital records for full traceability from pickup to delivery.
OpenPort’s logistics software solutions enable faster time to settlement and lower cost of finance for supply chains in Emerging Markets, backed by blockchain-enabled electronic Proof of Delivery (ePOD).
1. Approximately half a million USD of gross revenues per month and growing.
2. Key customers include Unilever, Nestlé and Colgate.
3. A new JV in the Philippines has successfully launched and is expected to double OpenPort’s top line revenue starting in November.
4. New Supply Chain Financing (SCF) product (OpenPaid) successfully launched in the Philippines, building partnerships with financing providers (banks and P2P lending platforms) in Asia and currently building a dedicated sales force to deploy OpenPaid into the SME ecosystem.
5. New agreements include a contract with Unilever Philippines signed in September 2018 (up to USD400k of additional revenues per month).
Detailed, immediate,and secure proof of delivery via digital record, replacing paper records.
Reduces fraud and increases trust by creating tamper-proof records with an audit trail.
Unique method of driving sustainable and compliant behaviour in network participants and obtaining accurate supply chain data direct from sources.
Configurable for different markets to support multinationals with adoption in major Asian countries.
Enables Supply Chain Finance
The only transport management system (TMS) in Asia that is already integrated with leading providers of supply chain finance.
Shipment Tracking from Start to Finish
We offer a digital transport procurement solution that is ERP-integrated and provides tracking,analytics, and instant proof of delivery which we use to drive lower costs and the fastest path to settlement available.
ERP-integrated OpenTM and OpenDispatch
OpenPort’s Transport Management (OpenTM) system gives shippers and transporters an enterprise-grade, fully integrated solution to tender and manage shipments, plan and consolidate loads, configure assets and driver resources, track and report shipment status, and all aspects of inbound and outbound transportation networks for anyone moving regular high volumes of freight.
Throughout the process shipment tracking events can be fed back to the customer’s internal systems. OpenPort is a proven integration partner with Oracle, SAP, JD Edwards and more.We have direct integrations whereby delivery requests from the shipper’s ERP are executed in OpenTM, consolidated and dispatched using the OpenDispatch tool, and fulfilled by drivers via the OpenPort Driver App.
2FA-enabled ePOD and Driver App
Built with practical usability in mind and designed to scale with varying degrees of detail, OpenPort’s electronic Proof of Delivery (ePOD), facilitated by our Driver App, provides real time shipment information at your fingertips with two-factor (2FA) authentication by the consignee.
Track and Trace
OpenPort’s Track and Trace feature provides status updates of shipment events regardless of the data source. OpenPort integrates data from most Vehicle Tracking Providers together with event, geofencing and breadcrumb data from its Driver App to provide data such as real-time location and navigation history so you don’t have to worry about consolidating sources of information.
Track performance and realize cost savings, operational efficiency, and increased ability to make informed decisions through a set of convenient and customizable operations dashboards that gather ERP, GPS, Driver App and other data from across your locations, shipments, and transport partners.
Improve Cash Flow with OpenPaid
We believe there is a need to directly connect the movement of goods with payment. Our electronic and blockchain-enabled ePOD, together with our financial partners, reduces the time to receive payments through paperless submission of electronic freight invoices and POD, facilitating faster approval and settlement for suppliers and transporters.
We estimate the current outsourced spend on trucking in Asia is over 143 billion USD per year, spent in a manual process and reliant on paper-based records for both the invoicing and payment between retailers, suppliers and transporters. Most deliveries in Asia that are negatively impacted (delayed, disputed, short paid, or not settled) are due to problems related to the manual paper process. Creating transparent and cost-effective supply chains with visibility, tracking and digital records for emerging Asia is one of the greatest challenges in the modern global economy, and we believe the change we drive here will change logistics around the world.
Max Ward, CEO and Founder
Previously the Vice President of Business Development APAC at Agility Logistics and the Head of Consumer Retail Asia at DHL, Max has over 10 years’ executive business development experience with leading logistics service providers in Asia, solving board-level supply chain problems for multinationals focused on the retail and consumer goods industries.
Prior, Max spent approximately 10 years in the I.T. arena at multiple “dot-com” start-ups in California’s Silicon Valley, trained as a systems engineer and worked for product development software companies in the US and Europe, before entering the logistics industry as a software product manager at APL Logistics in 2000.
Max is originally from the US, and holds an MBA from the Thunderbird School of Global Management. Max is thus one of the few individuals in the industry with a combination of technical I.T. knowledge and commercial sales management experience, and a true passion for combining the two in this exciting time for the logistics industry.
Paul Bell, CIO
Paul is a Supply Chain Technology professional with 20 years’ experience across Supply Chain Consulting, Solution Development and Business Transformation. Paul has extensive experience in building and delivering Supply Chain and Logistics Systems Programs for clients in Australia and across Asia. Paul is a commercially focused CIO who understands how to build software that delivers significant business value for its intended recipients.
Key skills include Agile Development, Product Management, Roadmap Build & Execution, Executive Stakeholder Management, Program Design and Management, Solution Design, Supply Chain Network Optimisation, &Business Case Development.
Nicolas Husson, CFO
Prior to joining OpenPort, Nicolas worked for BNP Paribas APAC investment banking division focusing on cross border merger and acquisition transactions in the Energy and Natural Resources sector in Asia.
Nicolas is a French national who graduated from Ecole Centrale Paris and Tsinghua University (MSc. in Industrial Engineering and Applied Mathematics) where he notably conducted quantitative supply chain optimization projects for Mitsubishi and PSA Peugeot Citroen.
Aamir Haroon, Managing Director, Middle East
With over 19 years of diversified experience in 3PLs, shipping and container freight; Aamir has held key positions in a wide range of logistics related industries in Pakistan, Dubai and Sri Lanka. His previous position was with Agility Logistics as Director Commercials where he worked closely with different industries on creating end-to-end logistics solutions.
Prior to that, he worked for several companies of the GAC Group- GAC Logistics Pakistan, Al-Hamd Container Terminal, GAC Dubai and GAC Srilanka. He holds an MBA in finance.
Pierre Carlo Curay, Country Manager, Philippines
Pierre has an unique combination of technology and logistics with extensive entrepreneurial experience. Information Technology professional by trade but an entrepreneur with different startups and traditional businesses for 22 years. Combined with 12 years experience in supply chain management with strengths on multi modal transport and distribution.
Sam Coyne, VP of Marketing
With 10 years’ experience in Asia, Sam holds B.Comm. & M.B.S. degrees earned in his home country of Ireland in addition to Renmin University of China and Nanyang Technological Institute of Singapore, while he currently resides in Hong Kong. Prior to OpenPort, he was marketing manager at the fastest growing supply chain quality control company in Asia.
He is experienced in branding, market strategy, digital marketing, campaign management, event planning, PR and communications for B2B startups and mid-sized enterprises.
Olga Dontsova, General Counsel
Olga is OpenPort’s General Counsel, overseeing all things law and compliance, from corporate governance to human resource management. Previously, Olga was in private practice at a boutique Hong Kong law firm where she split her focus between commercial transactional matters and dispute resolution. Olga hails from Russia via the US and is a Hong Kong solicitor.
Please Read Our Disclaimer
Location: Toronto, Ontario
TessPay operates a private permissioned blockchain solution that combines Smart Contracts and Automated Payments to guarantee daily settlements for cross border calls in the $65 billion USD Wholesale Telecoms Industry.
The Wholesale Telecoms Industry comprises international voice calls transmitted between telecommunications carriers in the course of completing a consumer-initiated call in one country to a consumer in another country.
Our business system features liquidity, payment assurance, lower fees, lower costs with an automated process. An easy-to-use solution means telecommunications carriers are seamlessly interconnected with and paid by other carriers and never have to deal with late or defaulted payments.
The TessPay Platform offers peace-of-mind; automated daily settlements guaranteeing all carriers are paid on time, every time. The TessPay Platform payment settlement system for Wholesale Telecom Services, caters to two categories of users: Carriers and Lenders.
Wholesale Telecom is a high volume, low margin business and as such credit losses are painful, and late payments create friction. All selling carriers on the TessPay Platform will be paid daily in full for the previous 24-hours call volume.
TessPay effects automated payments from the Smart Contract deposits and is able to calculate the precise amounts owing based on prices in the Smart Contract and the call volume that has passed through TessPay’s telecom switch.
The liquidity problem arises from the fact that due to the nature of the business, counterparts are almost always international, and the smaller carriers collectively supporting the large carrier receivables have difficulty granting and obtaining credit.
TessPay will provide lending opportunity for carriers. Lenders will have the opportunity to securely finance smaller carriers dealing with large carriers with strong credit ratings.
The Company is solving cashflow problems for smaller carriers by introducing lender supported funded Smart Contracts on the TessPay Platform.
The TessPay Platform will make settlements daily.
Payments are assured on daily basis.
Lower Operating Costs
On the TessPay Platform carriers pay only a modest service fee for volume based use. Carriers won’t be charged server, switching or billing fees.
Jeff Mason, CEO
In 1990, Jeff graduated with a BSc in Commerce and Economics from the University of Toronto. He next joined Ernst & Young LLP as a CPA and followed that as a business analyst at Canadian Tire.
In 1995 Jeff founded Wiznet Inc., an Internet service provider where he served as CEO until the company’s sale in 2004.
Jeff followed his previous success with the founding of Wiztel Inc., a VOIP telecommunications company that specialized in Wholesale Telecom cross-border voice calls. The company remained in operation until July 2017 when TessPay was founded.
In 2012, Jeff co-founded Limitless Mobile, a US/UK mobile virtual network operator. He served as CEO before divesting himself of his interest in the company to found Powercases Inc., in 2014. The company, where he remains a shareholder and Chairman, is a developer, marketer and seller of consumer and business portable power products based on Lithium ion technology.
Fraser Mason, CFO
Prior to Fraser’s role in TessPay, he began his storied business career as a senior partner at Ernst & Young Canada. Beginning in 1964, his many responsibilities included development and management of the Canadian corporate finance practice, management of the Canadian consulting practice and membership on the Canadian Executive Committee with a key role in the strategic growth of the firm until 2000.
As Chairman and CFO in the development and management of Champion Digital Links (formerly Champion Photochemistry), Fraser’s contributions since 1981 have included a series of cross border acquisitions that lead to a global business with operations in the United States, France and Malaysia. He also created a financing strategy for the business based on banking and credit insurance relationships developed in Spain.
Since 2014, Fraser has been a member of the advisory board for Newcom Media, a North American B2B publisher and industrial tradeshow company that focuses on trucking. Fraser recently facilitated a major acquisition for Newcom Media.
Fraser’s many qualifications include business strategy, corporate governance, financing, acquisition, deal negotiation, and global business management.
Please Read Our Disclaimer
Kalos Therapeutics Inc
Location: Phoenix, AZ
Sector: Life Sciences.
Kalos Therapeutics, Inc. is a biomedical company developing a class of therapeutic peptides to fight cancer. These peptides have already shown significant clinical activity in cardiovascular, cancer and veterinary indications. Kalos’ drugs replicate a natural, anti-proliferative activity by disrupting tubulin activity.
Our lead drug candidate, KTH-222, is a safe, non-toxic drug which may be used as 1) a front-line therapy, 2) a long-term maintenance therapy or 3) a co-therapy which reduces time to chemo resistance and minimizes chemo side-effects. KTH-222 reduces tumor size while addressing complications, such as metastasis, thereby, allowing the patient to maintain a quality of life not seen with chemo therapy treatments alone.
Initial cancer markets include: pancreatic, ovarian, prostate, lung and liver. An animal division will develop drugs for the treatment of cancer and renal disease, congestive heart failure and epistaxis.
KTH-222 – Human Cancer
Breakthrough technology – Novel therapeutic for unmet medical need in pancreatic cancer and associated complications like metastases.
Orphan Drug Designation – U.S. Orphan designation qualifies the sponsor to a seven-year period of market exclusivity upon approval of the drug. Sponsor may apply for FDA orphan research grants, a waiver of Prescription Drug User Fee Act filing fees andtax credits for clinical research costs.
Low to no toxicity, well tolerated and limited to no side effects – Our drug could be used as a lead therapy, a second line active therapy or potentially the first long-term maintenance therapy for many cancers. Based on its low/no toxicity, there is little risk of resistance and when used in combination, chemo amounts can be reduced with an improved quality of life for the patient.
KTH-222/variants – Canine Cancer
Pet owners are reluctant to subject their pets to chemotherapy based on Quality of Life (QOL), costs, and outcomes. KTH-222 is well tolerated, fewer, if any side effects, reduces primary tumor, address complications like metastases, improves QOL and can be used in combination with chemo should the owner desire.
KTH-222/variant – Retinal disease
Ease of delivery – Kalos has explored delivery of this therapy in retinal disease as a topical, delivered as a viscous drop, or applied to film. The goal is to eliminate or reduce injections into the eye as site fatigue is a problem and compliance of patients is difficult. This approach can be adapted in multiple eye diseases and KTH-222 should follow the pathway of testing previously completed with the parent peptide where vision was restored in AMD simulated animal models.
KTV-111 – Animal Epistaxis, Equine athletes
Focused on fluid removal to reduce bleeding in Equine Athletes – A well tolerated, potassium sparing approach to fluid removal to stop bleeding, additive benefits: regeneration of microtubules, and improvement of compromised heart function providing therapeutic benefits to the horses, while being compliant with regulations in each sport or event.
Quality-of-Life Safer, less toxic approach to slowing cancer with fewer side effects.
Safety/Toxicity Well tolerated. It is similar to amino acids found in the heart.
Addresses metastasis Our drug recognizes the metastasis and attacks these as small tumors. This is not being addressed by other therapies, and can lead to a long-term maintenance therapy and increased survival.
Synergistic Can be used in conjunction with existing therapies to provide a better quality-of-life and progression free survival.
Reduction of drug resistance When used synergistically with chemo, the amount of chemo used can be reduced thereby allowing a longer treatment cycle.
George Colberg, Co-Founder, CEO, Chairman
Mr. Colberg is a seasoned corporate finance and management executive. He was CEO of Primary Inc., a company where he pioneered the plan for acquisitions and the business model initiating early efforts in personalized medicine, electronic medical record meshed with patient data and billing and the advanced use of diagnostics. Prior to Primary Care he was a Vice President at the Financial Group managing syndications and equity investment research while raising in excess of $100 million.
Mr. Colberg developed the corporate philosophy of Kalos, identified and shaped the strategy behind the primary products, and the commercialization plan for Kalos. He raised the seed round, series A and B rounds and grant financing totaling $3.5 million. He recruited the executive team and scientific advisory board and oversees the clinical development plan. Mr. Colberg set the strategy for securing US and EU IP patents and the Orphan Drug Designation.
Mr. Colberg completed his Bachelor of Science from San Diego State University and attended University California, Berkeley for a Certification as a Biomedical Executive.
Jay Merritt, MD, President and Chief Medical Officer
Dr. Merritt is a medical oncologist with over 20 years’ experience as a biotechnology executive. He most recently served as President and Chief Medical Officer at Adventrx Pharmaceuticals. He was founding CEO of Imagine Pharmaceuticals, a venture stage company with a small molecule approach to facilitate drug uptake across the blood brain barrier.
He began his industrial career at the Upjohn Company leading early stage oncology and infectious diseases clinical research and he played a key role in launching Upjohn’s HIV research program. He subsequently held senior management positions at IDEC Pharmaceuticals (now Biogen Idec), Viagene Inc. and Introgen Therapeutics, successfully advancing ground-breaking biological modalities such as therapeutic monoclonal antibodies for cancer and rheumatologic diseases, and retroviral and adenoviral gene transfer technologies for cancer and HIV.
Dr. Merritt graduated from Johns Hopkins University and received an M.D. from the University of Vermont. He trained in Internal Medicine and Medical Oncology at the University of Wisconsin where he was also appointed Assistant Scientist in the Biophysics Laboratory.
Michael Kozlowski, PhD, Chief Science Officer
Dr. Michael Kozlowski is an Associate Professor at the Arizona College of Optometry (AZCOPT) at Midwestern University and CSO at Kalos therapeutics. Prior to Kalos, Dr. Kozlowski spent over 25 years in drug discovery and development for several clinical applications including cancer, age-related macular degeneration, and CNS disorders, and has over 40 peer-reviewed publications and over a dozen issued US patents.
He has worked with large pharmaceutical (Pfizer, BMS) and biotechnology companies (Geron, Telik, Axiom, Kreido Laboratories). Dr. Kozlowski has held positions ranging from Research Scientist to Chief Scientific Officer.
Dr. Kozlowski holds a BS in Biology from Caltech, a PhD in Neuroscience from the University of California at Irvine, and an OD from the New England College of Optometry.
Please Read Our Disclaimer
Location: Austin, Texas
As featured on the A&E hit reality show “Shipping Wars”, privately-held uShip (www.uShip.com) is a the world’s first and largest online shipping marketplace. uShip’s platform has enabled millions of customers and businesses to ship almost any category of large items such as freight, household goods, vehicles, and heavy equipment.
uShip’s dynamic spot marketplace allows customers to review and book with hundreds of thousands of transportation providers that can range from independent owner-operators to the world’s largest fleets, carriers and freight brokers.
Founded in 2003, uShip is headquartered in Austin, TX but operates globally with localized sites in 19 countries and regions on six continents. uShip is backed by the world’s most prestigious VC’s (Benchmark Capital, Kleiner-Perkins) and DB Schenker, the world’s third largest 3PL (2015).
- 2014 revenue: $139 MM
- 2015 revenue: $160 MM
- 2016 revenue: $178 MM
- Revenue growth rate: 11.3%
- Employee growth rate: 9%
- Jim Martell, who has been the Chairman of multiple extremely successful logistics companies, has recently become Chairman of the Board.
Total funding raised to date is $52.8 MM
- June 2005: Benchmark invests $2.7 MM
- October 2006: Benchmark and DAG Ventures invests $5.1 MM
- February 2011: Benchmark invests $2 MM
- December 2012: Kleiner, Perkins, Caufield & Byers (KPCB) invests $18 MM
- February 2017: Db Schenker Rail (UK) Limited invests $25MM
- uShip, the logistics technology company, today announced it has launched an in-home delivery service for e-commerce merchants selling large, heavy goods online.
- The company also says its delivery volume has doubled over the past three years.
- uShip’s successful pilot program with online seller Everything But The House (EBTH), the world’s premier online marketplace for authenticated second-hand items, and other e-commerce merchants processed over 12,000 fixed-price furniture deliveries to customers across the United States.
- Partners reported cutting delivery costs by nearly 50 percent, and reducing transit times by up to 65 percent, from 4-6 weeks to just 14 days.
- On uShip, a new shipment is posted every 20 seconds
- uShip’s less-than-truckload (LTL) instant rate platform has seen 52 percent annual transaction growth.
- Since 2004, uShip’s marketplace has facilitated the delivery of more than 2.2 million oversized items.